We at CPNP envision a world where every individual with a psychiatric or neurologic disorder has a care team that includes a psychiatric pharmacist accountable for optimal medication therapy.

In much the same way, CPNP hopes to make a real impact by being part of a team of organizations who share a common vision of patient care and the profession. We encourage you to further investigate these partnerships to learn more about how CPNP is working to make an impact.


AllTrials calls for all past and present clinical trials to be registered and their full methods and summary results reported. CPNP supports the AllTrials proposal to require universal clinical trial registration.

Board of Pharmacy Specialties (BPS)

Board certification through the Board of Pharmacy Specialties is recognized as the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels. Through rigorous standards, the BPS board certified pharmacist stands out as the most qualified to take on today’s expanding expectations of patients, physicians, employers and others who recognize the increasing need for a team approach to healthcare. CPNP is the sole provider of recertification education for the Board Certified Psychiatric Pharmacist (BCPP) credential from BPS.

Council on Credentialing in Pharmacy

The Council on Credentialing in Pharmacy (CCP) provides leadership, guidance, public information, and coordination for the profession of pharmacy's credentialing programs.  The vision of CCP is that all credentialing programs in pharmacy will meet established standards of quality and contribute to improvement in patient care and the overall public health.

FDA Network of Experts

CPNP is a member of the FDA Network of Experts, a joint project for efficiently exchanging information and knowledge between the FDA and leaders in emerging fields of science and pioneering technologies, including neuropsychiatric pharmacy. The primary objective is to permit FDA rapid access to various scientific viewpoints from individual experts with experience in new medical technologies, with the mutual goal of having more innovative, safe, and effective neuropsychiatric medical products on the market.

Joint Commission of Pharmacy Practitioners

JCPP was established in 1977 and serves as a forum on matters of common interest and concern to national organizations of pharmacy practitioners and invited liaison members.

National Alliance on Mental Illness

NAMI, the National Alliance on Mental Illness, is the nation’s largest grassroots mental health organization dedicated to building better lives for the millions of Americans affected by mental illness. CPNP contributes actively to NAMI through the creation and maintenance of the Mental Health Medication fact sheets (click on specific medications).

Partnership for Part D Access

The Partnership for Part D Access is a collection of healthcare stakeholders, including patient groups, advocacy organizations and allied members of industry, who are committed to maintaining beneficiary access to the full range of available medications under Medicare Part D.

Patient-Centered Primary Care Collaborative (PCPCC)

Founded in 2006, the Patient-Centered Primary Care Collaborative (PCPCC) is a not-for-profit membership organization dedicated to advancing an effective and efficient health system built on a strong foundation of primary care and the patient-centered medical home. The PCPCC is dedicated to transforming the U.S. health care system through delivery reform, payment reform, patient engagement, and benefit redesign.

Providers' Clinical Support System for Medication Assisted Treatment (PCSS-MAT)

PCSS-MAT is a national training and mentoring project developed in response to the prescription opioid misuse epidemic and the availability of newer pharmacotherapies to address opioid use disorder. The overarching goal of PCSS-MAT is to make available the most effective medication-assisted treatments to serve patients in a variety of settings, including primary care, psychiatric care, and pain management settings.

Providers' Clinical Support System for Opioid Therapies (PCSS-O)

PCSS-O is a national training and mentoring project developed in response to the prescription opioid overdose epidemic. The consortium of major stakeholders and constituency groups with interests in safe and effective use of opioid medications offers extensive experience in the treatment of substance use disorders and specifically, opioid use disorder treatment, as well as the interface of pain and opioid misuse. PCSS-O makes available at no cost CME programs on the safe and effective use of opioids for treatment of chronic pain and safe and effective treatment of opioid use disorder.